Kent Meningitis Outbreak: Cases Rise to 34, Vaccination Efforts Continue

The number of cases linked to the meningitis outbreak in Kent has risen to 34, with 23 laboratory-confirmed cases and 11 notifications still under investigation, according to the latest update from the UK Health Security Agency (UKHSA) on March 21, 2026. Sadly, two people have died as a result of the outbreak.

Outbreak Details and Vaccination Progress

As of 5pm on March 20, 2026, 4,500 vaccinations have been administered and over 10,500 doses of antibiotics have been given in response to the outbreak. More than 400 people, including students and other eligible individuals, queued outside the University of Kent campus clinic for meningitis jabs at the start of the weekend.

NHS Kent and Medway reported that, as of Friday evening, 5,794 vaccines had been administered and 11,010 antibiotics handed out across the county. Six clinics are currently operating in Kent, providing antibiotics and vaccines to those who are eligible.

Confirmed Cases and Strain Identification

The outbreak has been linked to the MenB strain of meningococcal bacteria. The initial outbreak, identified between March 13 and March 16, 2026, involved 15 cases of invasive meningococcal disease, with four confirmed as meningococcal group B [NHS England].

Who is at Risk and Receiving Treatment?

Preventative antibiotics are being offered to close contacts of confirmed or suspected cases, as well as students at the University of Kent who normally reside on the Canterbury Campus, including those who have returned home. Some staff living or working in these Halls of Residence are likewise eligible for antibiotics and vaccination [UKHSA Blog].

Symptoms and Public Health Advice

The UKHSA emphasizes the importance of being aware of the signs and symptoms of invasive meningococcal disease and seeking immediate medical attention if symptoms develop. Transmission of MenB requires close and prolonged contact, such as living in the same household or through intimate contact like kissing or sharing vapes. The bacteria are not as contagious as infections like measles or COVID-19 [UKHSA Blog].

Expert Commentary

Dr. Ben Rush, Consultant in Communicable Disease Control at UKHSA, stated, “We continue to remain vigilant for new cases and work closely with NHS England and local authorities across the country to ensure enhanced surveillance is in place. Any new cases will be identified quickly and responded to.” [Gov.uk]

Recent Developments

Experts are analyzing the strain of MenB to determine if it has grow more likely to spread or cause disease. While the growth in cases may have slowed, the situation remains serious, with all cases requiring hospital admission. As of Thursday, March 20, 2026, 2,360 vaccinations had been given and 9,840 doses of antibiotics handed out [The Guardian].

The UKHSA continues to work with partners to identify contacts and offer necessary treatment. The risk to the wider population remains low.